229 related articles for article (PubMed ID: 23273222)
1. Role of metallothioneins in benign and malignant thyroid lesions.
Pula B; Domoslawski P; Podhorska-Okolow M; Dziegiel P
Thyroid Res; 2012 Dec; 5(1):26. PubMed ID: 23273222
[TBL] [Abstract][Full Text] [Related]
2. Metallothionein Isoform Expression in Benign and Malignant Thyroid Lesions.
Wojtczak B; Pula B; Gomulkiewicz A; Olbromski M; Podhorska-Okolow M; Domoslawski P; Bolanowski M; Daroszewski J; Dziegiel P
Anticancer Res; 2017 Sep; 37(9):5179-5185. PubMed ID: 28870952
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical expression of HBME-1 and galectin-3 in the differential diagnosis of follicular-derived thyroid nodules.
Abd-El Raouf SM; Ibrahim TR
Pathol Res Pract; 2014 Dec; 210(12):971-8. PubMed ID: 25041837
[TBL] [Abstract][Full Text] [Related]
4. Role of CD10 Marker in Differentiating Malignant Thyroid Neoplasms from Benign Thyroid Lesions (Immunohistochemical & Histopathological Study).
Gabal SM; Salem MM; Mostafa RR; Abdelsalam SM
Open Access Maced J Med Sci; 2018 Dec; 6(12):2295-2300. PubMed ID: 30607179
[TBL] [Abstract][Full Text] [Related]
5. CD56 expression in benign and malignant thyroid lesions.
Muthusamy S; Azhar Sha S; Abdullah Suhaimi SN; Kassim N; Mahasin M; Mohd Saleh MF; Md Isa N
Malays J Pathol; 2018 Aug; 40(2):111-119. PubMed ID: 30173227
[TBL] [Abstract][Full Text] [Related]
6. BRAF(V600E) Mutation, RET/PTC1 and PAX8-PPAR Gamma Rearrangements in Follicular Epithelium Derived Thyroid Lesions - Institutional Experience and Literature Review.
Şahpaz A; Önal B; Yeşilyurt A; Han Ü; Delibaşı T
Balkan Med J; 2015 Apr; 32(2):156-66. PubMed ID: 26167339
[TBL] [Abstract][Full Text] [Related]
7. Latency period of thyroid neoplasia after radiation exposure.
Kikuchi S; Perrier ND; Ituarte P; Siperstein AE; Duh QY; Clark OH
Ann Surg; 2004 Apr; 239(4):536-43. PubMed ID: 15024315
[TBL] [Abstract][Full Text] [Related]
8. Utility of immunohistochemical markers in differentiating benign from malignant follicular-derived thyroid nodules.
Saleh HA; Jin B; Barnwell J; Alzohaili O
Diagn Pathol; 2010 Jan; 5():9. PubMed ID: 20181018
[TBL] [Abstract][Full Text] [Related]
9. APLP2, RRM2, and PRC1: New Putative Markers for the Differential Diagnosis of Thyroid Follicular Lesions.
Castelblanco E; Zafon C; Maravall J; Gallel P; Martinez M; Capel I; Bella MR; Halperin I; Temprana J; Iglesias C; Puig-Domingo M; Robledo M; Matias-Guiu X; Mauricio D
Thyroid; 2017 Jan; 27(1):59-66. PubMed ID: 27796194
[TBL] [Abstract][Full Text] [Related]
10. Implications of follicular neoplasms, atypia, and lesions suspicious for malignancy diagnosed by fine-needle aspiration of thyroid nodules.
Goldstein RE; Netterville JL; Burkey B; Johnson JE
Ann Surg; 2002 May; 235(5):656-62; discussion 662-4. PubMed ID: 11981211
[TBL] [Abstract][Full Text] [Related]
11. Papillary and follicular thyroid cancers in children.
Vasko V; Bauer AJ; Tuttle RM; Francis GL
Endocr Dev; 2007; 10():140-172. PubMed ID: 17684395
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis and reporting of follicular-patterned thyroid lesions by fine needle aspiration.
Faquin WC
Head Neck Pathol; 2009 Mar; 3(1):82-5. PubMed ID: 20596996
[TBL] [Abstract][Full Text] [Related]
13. Expression of HBME-1 and CD56 in follicular variant of papillary carcinoma in children: An immunohistochemical study and their diagnostic utility.
Skaria PE; Ahmed AA; Yin H; Nicol K; Reid KJ; Singh V
Pathol Res Pract; 2019 May; 215(5):880-884. PubMed ID: 30711197
[TBL] [Abstract][Full Text] [Related]
14. Utility of frozen section analysis on follicular lesions of the thyroid.
Bronner MP; Hamilton R; LiVolsi VA
Endocr Pathol; 1994 Sep; 5(3):154-161. PubMed ID: 32138424
[TBL] [Abstract][Full Text] [Related]
15. Can misdiagnosis in pre-operative FNAC of thyroid nodule influence surgical treatment?
Del Rio P; Minelli R; Cataldo S; Ceresini G; Robuschi G; Corcione L; Guazzi A; Nizzoli R; Sianesi M
J Endocrinol Invest; 2011 May; 34(5):345-8. PubMed ID: 20588087
[TBL] [Abstract][Full Text] [Related]
16. Retinoblastoma expression in thyroid neoplasms.
Anwar F; Emond MJ; Schmidt RA; Hwang HC; Bronner MP
Mod Pathol; 2000 May; 13(5):562-9. PubMed ID: 10824929
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of CD56 and nm23 markers in papillary thyroid carcinoma.
Shahebrahimi K; Madani SH; Fazaeli AR; Khazaei S; Kanani M; Keshavarz A
Indian J Pathol Microbiol; 2013; 56(1):2-5. PubMed ID: 23924549
[TBL] [Abstract][Full Text] [Related]
18. Cytologic Diagnosis of Noninvasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features and Its Impact on the Risk of Malignancy in the Bethesda System for Reporting Thyroid Cytopathology: An Institutional Experience.
Kim M; Kim JE; Kim HJ; Chung YR; Kwak Y; Park SY
J Pathol Transl Med; 2018 May; 52(3):171-178. PubMed ID: 29614546
[TBL] [Abstract][Full Text] [Related]
19. Study of Immunohistochemical Markers (CK-19, CD-56, Ki-67, p53) in Differentiating Benign and Malignant Solitary Thyroid Nodules with special Reference to Papillary Thyroid Carcinomas.
Dwivedi SS; Khandeparkar SG; Joshi AR; Kulkarni MM; Bhayekar P; Jadhav A; Nayar M; Kambale NS
J Clin Diagn Res; 2016 Dec; 10(12):EC14-EC19. PubMed ID: 28208864
[TBL] [Abstract][Full Text] [Related]
20. The diagnostic utility of cytokeratin 19 in differentiating malignant from benign thyroid lesions.
Wa Kammal WS; Yahaya A; Shah SA; Abdullah Suhaimi SN; Mahasin M; Mustangin M; Md Isa N
Malays J Pathol; 2019 Dec; 41(3):293-301. PubMed ID: 31901914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
